Skip to main content
. 2010 Aug 20;13(8):803–808. doi: 10.3779/j.issn.1009-3419.2010.08.10

1.

1

Immunostaining of NSCLC in serial sections. A: negative contrast; B: adenocarcinoma with positive expression of cyclin D1; C: squamous cell carcinoma with positive expression of cyclin D1.